TiO₂ nanoparticles induce insulin resistance in liver-derived cells both directly and via macrophage activation

Abstract

Upon exposure, TiO₂ nanoparticles (NPs) have been recovered in internal organs such as the liver, and are proposed to cause cellular/organ dysfunction, particularly in the liver and lungs. We hypothesized that despite being considered “inert” as bulk material, TiO₂ NPs may impair insulin responses in liver-derived cells, either indirectly by inflammatory activation of macrophages, and/or by directly interfering with insulin signaling. Using qRT-PCR and conditioned medium (CM) approaches, we show that exposure to TiO₂ NPs activates macrophages' expression of TNF-α, IL-6, IL-8, IL-1α and IL-1β and the resulting CM induces insulin resistance in Fao cells. Furthermore, direct exposure of Fao cells to TiO₂ results in activation of the stress kinases JNK and p38MAP kinase, and in induction of insulin resistance at the signaling and metabolic levels. Collectively, our findings provide a proof-of-concept for the ability of man-made NPs to induce insulin resistance in liver-derived cells, an endocrine abnormality underlying some of the most common human diseases.

Keywords::

• Inflammation
• insulin resistance
• liver
• macrophages
• TiO₂

Acknowledgments

YR acknowledges support by the Helen and Martin Kimmel Award for Innovative Investigation. This work was partially supported by the CNRS-Weizmann NABI initiative (YR), Grant 1103-09 from the Israel Science Foundation (to AR) and the Leslie Gonda fund (to AR).